This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Associated conditions

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Associated conditions causing secondary Raynaud's phenomenon are as follows:

  • rheumatological
  • systemic sclerosis - 90% of patients with this condition have Raynaud’s phenomenon)
  • mixed connective tissue disease - 85%
  • systemic lupus erythematosus - 40%
  • dermatomyositis or polymyositis - 25%
  • rheumatoid arthritis - 10%
  • sjögren’s syndrome
  • vasculitis
  • haematological
  • polycythaemia ruba vera
  • leukaemia
  • thrombocytosis
  • cold agglutinin disease (Mycoplasma infections)
  • paraproteinaemias
  • protein C deficiency, protein S deficiency, antithrombin III deficiency
  • presence of the factor V Leiden mutation
  • hepatitis B and C (associated with cryoglobulinaemia)
  • occlusive arterial disease
  • external neurovascular compression, carpal tunnel syndrome, and thoracic outlet syndrome
  • thrombosis
  • thromboangiitis obliterans
  • embolisation
  • arteriosclerosis
  • buerger’s disease
  • other
  • hand-arm-vibration syndrome (vibration white finger)
  • drugs, chemicals, or other occupational exposures e.g. - Beta-blockers, Vinyl chloride, tobacco, bleomycin
  • endocrine disorders - hypothyroidism, phaeochromocytoma, carcinoid syndrome
  • occult carcinoma
  • infections - parvovirus B19, Helicobacter pylori (1,2,3)

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.